We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Grassley Demands HHS Committee Hearing on Blood Substitute Study
Grassley Demands HHS Committee Hearing on Blood Substitute Study
October 20, 2006
On the same day that the FDA held a public hearing on clinical research conducted under an emergency exception rule, Sen. Chuck Grassley (R-Iowa) sent a letter to HHS Secretary Mike Leavitt requesting that he convene a meeting of the Secretary’s Advisory Committee on Human Research Protections (SACHRP) to address a controversial study of a blood substitute that is being done under that rule.